Nvidia Work in process increased by 12.8% to $9.95B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 86.3%, from $5.34B to $9.95B. Over 5 years (FY 2021 to FY 2026), Work in process shows an upward trend with a 80.8% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase may indicate production bottlenecks or scaling efforts, while a decrease suggests efficient throughput or reduced manufacturing activity.
Represents the value of goods that have entered the production process but are not yet finished. For a manufacturer like...
Peers in medical device manufacturing typically maintain lean WIP levels to optimize cash conversion cycles.
inv_work_in_progress| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 | Q4 '26 | Q1 '27 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $504.00M | $553.00M | $538.00M | $692.00M | $672.00M | $767.00M | $788.00M | $466.00M | $930.00M | $1.06B | $1.34B | $1.51B | $1.63B | $2.11B | $2.88B | $3.40B | $5.34B | $4.41B | $8.74B | $8.82B | $9.95B |
| QoQ Change | — | +9.7% | -2.7% | +28.6% | -2.9% | +14.1% | +2.7% | -40.9% | +99.6% | +13.8% | +26.5% | +12.5% | +8.0% | +29.9% | +36.5% | +18.0% | +57.1% | -17.4% | +98.0% | +1.0% | +12.8% |
| YoY Change | — | — | — | — | +33.3% | +38.7% | +46.5% | -32.7% | +38.4% | +37.9% | +69.8% | +223.0% | +74.7% | +99.5% | +115.3% | +125.8% | +228.6% | +109.0% | +203.2% | +159.5% | +86.3% |
| % of Inventories | 25.3% | 26.2% | 24.1% | 26.6% | 21.2% | 19.7% | 17.7% | 9.0% | 20.2% | 24.5% | 28.0% | 28.5% | 27.7% | 31.6% | 37.6% | 33.7% | 47.1% | 29.5% | 44.2% | 41.2% | 38.6% |
| Share Change | — | +0.9pp | -2.1pp | +2.5pp | -5.3pp | -1.5pp | -2.0pp | -8.7pp | +11.1pp | +4.3pp | +3.5pp | +0.5pp | -0.8pp | +3.9pp | +6.0pp | -3.9pp | +13.4pp | -17.6pp | +14.7pp | -2.9pp | -2.7pp |